| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2025 | BMY Bristol Myers Squibb Co | Hirawat Samit53 | EVP,Chief Med.offr.,Drug Dev. | Buy | 4,250 | $47.58 | $202,215.00 | +5.4% | +2.2% | +22.6% | |
| Apr 25, 2025 | MRK Merck & Co., Inc. | Smart Dalton E. III | SVP Fin. - Global Controller | Sell | 4,262 | $82.76 | $352,723.12 | -35.4% | +1.7% | +35.2% | |
| Apr 22, 2025 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 2,936 | $26.49 | $77,774.64 | -36.7% | +87.8% | - | |
| Apr 21, 2025 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 33,333 | $25.78 | $859,256.11 | -2.0% | +84.2% | - | |
| Apr 21, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Moat Ross | Chief Commercial Officer | Sell | 18,259 | $20.29 | $370,475.11 | -66.0% | +41.7% | - | |
| Apr 21, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 2,450 | $13.67 | $33,491.50 | -0.9% | +13.6% | - | |
| Apr 21, 2025 | UTHR United Therapeutics Corp | Dwek Raymond | Director | Sell | 3,000 | $285.57 | $856,710.00 | -63.2% | +3.1% | - | |
| Apr 17, 2025 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 108 | $0.98 | $105.62 | - | +17.9% | - | |
| Apr 17, 2025 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | 8 | $0.96 | $7.71 | - | +17.9% | - | |
| Apr 17, 2025 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 11,000 | $283.78 | $3,121,543.06 | -6.1% | +4.7% | - | |
| Apr 16, 2025 | HIMS Hims & Hers Health, Inc. | Dudum Andrew47 | Chief Executive Officer | Sell | 83,994 | $28.15 | $2,364,547.13 | -13.9% | +87.2% | - | |
| Apr 15, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 11,581 | $28.50 | $330,081.66 | -8.9% | +76.6% | -34.0% | |
| Apr 15, 2025 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 3,406 | $13.57 | $46,219.42 | -1.6% | +6.5% | +183.5% | |
| Apr 14, 2025 | TXMD Therapeuticsmd, Inc. | Thompson Tommy G51 | - | Buy | 325 | $1.00 | $325.59 | +2.2% | +13.6% | +101.0% | |
| Apr 14, 2025 | TXMD Therapeuticsmd, Inc. | Walker Marlan D81 | Chief Executive Officer | Buy | 490 | $1.00 | $489.27 | +0.7% | +13.6% | +101.0% | |
| Apr 14, 2025 | ANIP Ani Pharmaceuticals Inc | Cook Meredith50 | Sr. VP, General Counsel &Sec. | Sell | 400 | $68.96 | $27,584.00 | -0.5% | -5.1% | +14.0% | |
| Apr 14, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 12,000 | $20.48 | $245,811.55 | -6.9% | +39.2% | +127.5% | |
| Apr 14, 2025 | LQDA Liquidia Corp | Jeffs Roger66 | Chief Executive Officer | Sell | 14,130 | $13.57 | $191,744.10 | -1.4% | +4.7% | +178.7% | |
| Apr 14, 2025 | UTHR United Therapeutics Corp | Dwek Raymond | Director | Sell | 3,000 | $285.16 | $855,480.00 | -63.2% | +4.7% | +101.1% | |
| Apr 14, 2025 | LQDA Liquidia Corp | Kaseta Michael57 | CFO And COO | Sell | 8,283 | $13.57 | $112,400.31 | -2.0% | +4.7% | +178.7% | |
| Apr 14, 2025 | LQDA Liquidia Corp | Schundler Russell58 | General Counsel | Sell | 5,964 | $13.57 | $80,931.48 | -1.0% | +4.7% | +178.7% | |
| Apr 14, 2025 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 3,714 | $13.57 | $50,398.98 | -1.4% | +4.7% | +178.7% | |
| Apr 14, 2025 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 1,856 | $13.57 | $25,185.92 | -1.0% | +4.7% | +178.7% | |
| Apr 14, 2025 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 7,387 | $37.95 | $280,314.06 | -2.2% | +83.8% | -31.4% | |
| Apr 11, 2025 | RMTI Rockwell Medical, Inc. | Irrevocable Larson Family Investment Trust | 10% Owner | Buy | 87,500 | $1.07 | $94,017.70 | - | +21.7% | -14.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.